The search of the target of promotion: Phenylbenzoate esterase activities in hen peripheral nerve

Toxicology and Applied Pharmacology

Volumn 219, Issue 2-3, 2007, Pages 196-201

  Moretto, A ^a   Nicolli, A ^a   Lotti, M ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Axonopathy; Esterase; Promotion

Indexed keywords

4 TOLUENESULFONYL FLUORIDE; BENZOIC ACID DERIVATIVE; BENZYLSULFONYL FLUORIDE; CARBAMIC ACID DERIVATIVE; DIBUTYLDICHLOROVINYLPHOSPHATE; DYFLOS; ESTERASE; MIPAFOX; NEUROTOXIC ESTERASE; ORGANOPHOSPHATE; PARAOXON; PHENYLBENZOATE; PHENYLBENZOATE ESTERASE; PHENYLBENZYLCARBAMATE; PHENYLVALERATE ESTERASE; PHOSPHINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; FEMALE; HEN; IC 50; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY;

ANIMALS; BENZOATES; CARBOXYLIC ESTER HYDROLASES; CHICKENS; ENZYME INHIBITORS; ISOFLUROPHATE; PHENYLMETHYLSULFONYL FLUORIDE; SCIATIC NERVE; SUBSTRATE SPECIFICITY;

EID: 33847168958     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.11.025     Document Type: Article

References (23)

1. Akassoglou K., Malester B., Xu J., Tessarollo L., Rosenbluth J., and Chao M.V. Brain-specific deletion of neuropathy target esterase/swisscheese results in neurodegeneration. Proc. Natl. Acad. Sci. 101 (2004) 5075-5080
2. Caroldi S., and Lotti M. Neurotoxic esterase in peripheral nerve: assay, inhibition, and rate of resynthesis. Toxicol. Appl. Pharmacol. 62 3 (1982) 498-501
3. Johnson M.K. Structure activity relationships for substrates and inhibitors of hen brain neurotoxic esterase. Biochem. Pharmacol. 24 (1975) 797-805
4. Johnson M.K. Improved assay of neurotoxic esterase for screening organophosphate for delayed neurotoxicity potential. Arch. Toxicol. 37 (1977) 113-115
5. Johnson M.K. Organophosphates and delayed neuropathy-is NTE alive and well?. Toxicol. Appl. Pharmacol. 102 (1990) 385-399
6. Lotti M. The pathogenesis of organophosphate delayed polyneuropathy. Crit. Rev. Toxicol. 21 (1992) 465-487
7. Lotti M., and Moretto A. Promotion of organophosphate induced delayed polyneuropathy by certain esterase inhibitors. Chem. -Biol. Interact. 119-120 (1999) 519-524
8. Lotti M., Caroldi S., Capodicasa E., and Moretto A. Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol. Appl. Pharmacol. 108 (1991) 234-241
9. Milatovic D., Moretto A., Osman K.A., and Lotti M. Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Chem. Res. Toxicol. 10 (1997) 1045-1048
10. Moretto A., Lotti M., and Spencer P.S. In vivo and in vitro regional differential sensitivity of neuropathy target esterase to di-n-butyl-2,2 dichlorovinyl phosphate. Arch. Toxicol. 63 (1989) 469-473
11. Moretto A., Bertolazzi M., Capodicasa E., Peraica M., Richardson R.J., Scapellato M.L., and Lotti M. Phenylmethanesulfonyl fluoride elicits and intensifies the clinical expression of neuropathic insults. Arch. Toxicol. 66 (1992) 67-72
12. Moretto A., Capodicasa E., Peraica M., and Lotti M. Phenylmethanesulfonyl fluoride delays recovery from crush of peripheral nerves in hens. Chem.-Biol. Interact. 87 (1993) 457-462
13. Moretto A., Bertolazzi M., and Lotti M. The phosphorothioic acid-O-(2-chloro-2,3,3-tri-fluorocyclobutyl)-O-ethyl S-propyl ester promotes organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxicol. Appl. Pharmacol. 129 (1994) 133-137
14. Moretto A., Gardiman G., Panfilo S., Colle M.A., Lock E.A., and Lotti M. Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (Molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy. Toxicol. Sci. 62 (2001) 274-279
15. Moretto A., Nicolli A., and Lotti M. Peripheral nerve esterases and the promotion of organophosphate-induced neuropathy in hens. Chem.-Biol. Interact. 157-158 (2005) 285-291
16. Osman K.A., Moretto A., and Lotti M. Sulfonylfluorides and the promotion of diisopropyl-fluorophosphate neuropathy. Fund. Appl. Toxicol. 33 (1996) 294-297
17. Peraica M., Capodicasa E., Moretto A., and Lotti M. Organophosphate polyneuropathy in chicks. Biochem. Pharmacol. 45 (1993) 131-135
18. Pope C.N., and Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J. Toxicol. Environ. Health. 31 (1990) 261-273
19. Quistad G.B., and Casida J.E. Lysophospholipase inhibition by organophosphorus toxicants. Toxicol. Appl. Pharmacol. 196 (2004) 319-326
20. Quistad G.B., Barlow C., Winrow C.J., Sparks S.E., and Casida J.E. Evidence that mouse brain neuropathy target esterase is a lysophospholipase. Proc. Natl. Acad. Sci. 100 (2003) 7983-7987
21. Van Tienhoven M., Atkins J., Li Y., and Glynn P. Human neuropathy target esterase catalyzes hydrolysis of membrane lipids. J. Biol. Chem. 277 (2002) 20942-20948
22. Winrow C., Hemming M.L., Allen D.M., Quistad G.B., Casida J.E., and Barlow C. Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivity. Nat. Genet. 33 (2003) 477-485
23. Zaccheo O., Dinsdale D., Meacock P.A., and Glynn P. Neuropathy target esterase and its yeast homologue degrade phosphatidylcholine to glycerophosphocholine in living cells. J. Biol. Chem. 279 (2004) 24024-24033